355 related articles for article (PubMed ID: 17308321)
41. Formaldehyde-fixation of platelets for flow cytometric measurement of phosphatidylserine exposure is feasible.
Rochat S; Alberio L
Cytometry A; 2015 Jan; 87(1):32-6. PubMed ID: 25266200
[TBL] [Abstract][Full Text] [Related]
42. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups.
Dachary-Prigent J; Freyssinet JM; Pasquet JM; Carron JC; Nurden AT
Blood; 1993 May; 81(10):2554-65. PubMed ID: 8490169
[TBL] [Abstract][Full Text] [Related]
43. Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation.
Bae ON; Lim KM; Noh JY; Chung SM; Kim SH; Chung JH
Toxicol Appl Pharmacol; 2009 Sep; 239(2):144-53. PubMed ID: 19167414
[TBL] [Abstract][Full Text] [Related]
44. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
Kumar R; Béguin S; Hemker HC
Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
[TBL] [Abstract][Full Text] [Related]
45. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting.
Podoplelova NA; Sveshnikova AN; Kotova YN; Eckly A; Receveur N; Nechipurenko DY; Obydennyi SI; Kireev II; Gachet C; Ataullakhanov FI; Mangin PH; Panteleev MA
Blood; 2016 Sep; 128(13):1745-55. PubMed ID: 27432876
[TBL] [Abstract][Full Text] [Related]
46. Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: elimination of the feedback activation of platelets by thrombin.
Jesty J; Bluestein D
Anal Biochem; 1999 Jul; 272(1):64-70. PubMed ID: 10405294
[TBL] [Abstract][Full Text] [Related]
47. Agonist-induced platelet procoagulant activity requires shear and a Rac1-dependent signaling mechanism.
Delaney MK; Liu J; Kim K; Shen B; Stojanovic-Terpo A; Zheng Y; Cho J; Du X
Blood; 2014 Sep; 124(12):1957-67. PubMed ID: 25079357
[TBL] [Abstract][Full Text] [Related]
48. Daunorubicin induces procoagulant response through phosphatidylserine exposure in red blood cells.
Zhou J; Zheng Y; Shi J; Lu C; Hou J; Yu H; Qiao X; Qi S; Gilbert GE
Thromb Res; 2010 Feb; 125(2):178-83. PubMed ID: 19800661
[TBL] [Abstract][Full Text] [Related]
49. Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
Galan AM; Lopez-Vilchez I; Diaz-Ricart M; Navalon F; Gomez E; Gasto C; Escolar G
Thromb Haemost; 2009 Sep; 102(3):511-9. PubMed ID: 19718472
[TBL] [Abstract][Full Text] [Related]
50. Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood.
Bombeli T; Müller M; Straub PW; Haeberli A
J Lab Clin Med; 1996 Jun; 127(6):621-34. PubMed ID: 8648267
[TBL] [Abstract][Full Text] [Related]
51. Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins.
Wielders SJ; Ungethüm L; Reutelingsperger CP; Bevers EM; Lindhout T
Thromb Haemost; 2007 Nov; 98(5):1056-62. PubMed ID: 18000611
[TBL] [Abstract][Full Text] [Related]
52. Platelet activation and blood coagulation.
Heemskerk JW; Bevers EM; Lindhout T
Thromb Haemost; 2002 Aug; 88(2):186-93. PubMed ID: 12195687
[TBL] [Abstract][Full Text] [Related]
53. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.
Rand ML; Wang H; Pluthero FG; Stafford AR; Ni R; Vaezzadeh N; Allison AC; Kahr WH; Weitz JI; Gross PL
J Thromb Haemost; 2012 Jun; 10(6):1109-19. PubMed ID: 22463102
[TBL] [Abstract][Full Text] [Related]
54. Platelet activation is increased in cyclosporin A-induced hypertensive rats.
Reis F; Tavares P; Rito LC; Teixeira HM; Santos Dias JD; Ferrer-Antunes C; Mesquita JF; Teixeira F
J Cardiovasc Pharmacol; 2000 Jul; 36(1):56-64. PubMed ID: 10892661
[TBL] [Abstract][Full Text] [Related]
55. Alpha-tocopherol modulates phosphatidylserine externalization in erythrocytes: relevance in phospholipid transfer protein-deficient mice.
Klein A; Deckert V; Schneider M; Dutrillaux F; Hammann A; Athias A; Le Guern N; Pais de Barros JP; Desrumaux C; Masson D; Jiang XC; Lagrost L
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2160-7. PubMed ID: 16825594
[TBL] [Abstract][Full Text] [Related]
56. The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impacton the coagulant function of stored platelets.
Shapira S; Friedman Z; Shapiro H; Presseizen K; Radnay J; Ellis MH
Transfusion; 2000 Oct; 40(10):1257-63. PubMed ID: 11061865
[TBL] [Abstract][Full Text] [Related]
57. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
[TBL] [Abstract][Full Text] [Related]
58. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
[TBL] [Abstract][Full Text] [Related]
59. The procoagulant properties of hyaluronic acid-collagen (I)/chitosan complex film.
Hu Y; Wu Y; Cai J; Ma S; Wang X
J Biomater Sci Polym Ed; 2009; 20(7-8):1111-8. PubMed ID: 19454172
[TBL] [Abstract][Full Text] [Related]
60. Platelet lipidomic.
Dolegowska B; Lubkowska A; De Girolamo L
J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):23S-33S. PubMed ID: 23648196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
